Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act After Class Action Is Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman, LLC, a law firm focused on investor-rights matters, announced that it has filed a class action lawsuit against uniQure N.V. (NASDAQ: QURE) and certain of its officers. The lawsuit seeks to recover damages for alleged violations of federal securities laws on behalf of investors who purchased or otherwise acquired uniQure securities between September 24, 2025 and October 31, 2025, inclusive.

Allegations in the complaint

The complaint alleges that the defendants made materially false and/or misleading statements and failed to disclose material adverse facts about the company’s business and operations. It specifically alleges that defendants misrepresented and/or failed to disclose the following:

• That the design of uniQure’s Pivotal Study, including how the Pivotal Study results were compared to the ENROLL-HD external historical data set, was not fully approved by the FDA.
• That defendants downplayed the likelihood that, despite purportedly highly successful Pivotal Study results, uniQure would need to delay its BLA timeline to perform additional studies to supplement its BLA submission.
• That, as a result, defendants’ statements about the company’s business, operations, and prospects lacked a reasonable basis.

What investors can do next

The firm states that a class action lawsuit has already been filed. Investors seeking to review the complaint can do so via the firm’s website at bgandg.com/QURE or by contacting the firm’s client relations team.

The firm also states that investors who suffered losses in uniQure have until April 13, 2026 to request that the court appoint them as lead plaintiff. It notes that the ability to share in any recovery does not require serving as lead plaintiff.

No cost on a contingency-fee basis

Bronstein, Gewirtz & Grossman, LLC says it represents investors in class actions on a contingency fee basis. Under this arrangement, the firm will seek reimbursement for out-of-pocket expenses and attorneys’ fees—typically as a percentage of any total recovery—only if the case is successful.

Firm statement and contact information

Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC, said the firm’s practice focuses on restoring investor capital and ensuring corporate accountability.

For inquiries, the firm lists the following contact details: Peretz Bronstein, Esq. or Nathan Miller, Bronstein, Gewirtz & Grossman, LLC, 917-590-0911, info@bgandg.com.

Attorney advertising. Prior results do not guarantee similar outcomes.